{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:04:19Z","timestamp":1784610259034,"version":"3.55.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Carbohydrate antigen 19-9 (CA19-9) is a well-established tumour marker primarily associated with pancreaticobiliary and gastrointestinal malignancies. Its elevation in benign gynaecological conditions, particularly in isolated ovarian endometriosis (OE) without malignancy, is rare and can pose a significant diagnostic challenge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>In this case report, a 44-year-old female was found to have significantly elevated CA19-9 (up to 2453.1 U\/mL), accompanied by left lower abdominal dull pain and weight loss. She was first diagnosed with an ovarian cyst more than 20 years ago, which resolved during pregnancy and recurred postpartum with no special intervention due to the absence of clinical symptoms. Extensive workup, including gastroenterological endoscopy and abdominal magnetic resonance imaging (MRI), excluded gastrointestinal malignancies. Laparoscopy followed by pathological examination confirmed the diagnosis of an ovarian endometriotic cyst (chocolate cyst). Postoperatively, the patient received standardised endocrine therapy, and follow-up assessments showed that serum CA19\u20139 levels returned to the normal range with no evidence of lesion recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>For female patients with elevated CA19\u22129 combined with a long\u2212standing ovarian cyst and pelvic symptoms, ovarian malignancy should be suspected after excluding gastrointestinal lesions. However, benign diseases should also be considered. The final diagnosis should be based on comprehensive clinical evaluation, additional laboratory and imaging findings, and ultimately confirmed by pathological biopsy. Clinicians need to strengthen the cognitive understanding of this atypical manifestation to reduce misdiagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1846804","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:20:42Z","timestamp":1784607642000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Ovarian endometriosis associated with significantly elevated CA19-9: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Yue","family":"Hu","sequence":"first","affiliation":[{"name":"Graduate School, Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]},{"name":"The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Shenzhen, China"]},{"name":"Department of Gynecology, Shenzhen Hospital of Traditional Chinese Medicine","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Ruan","sequence":"additional","affiliation":[{"name":"Graduate School, Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]},{"name":"The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Du","sequence":"additional","affiliation":[{"name":"Graduate School, Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]},{"name":"The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Shenzhen, China"]},{"name":"Department of Gynecology, Shenzhen Hospital of Traditional Chinese Medicine","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-017-7215-0_15","article-title":"CA 19-9: Biochemical and Clinical Aspects","volume":"867","author":"Scar\u00e0","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"12745","DOI":"10.18632\/oncotarget.23993","article-title":"Significant increased CA199 levels in acute pancreatitis patients predicts the presence of pancreatic cancer","volume":"9","author":"Teng","year":"2018","journal-title":"Oncotarget"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/hpb.12448","article-title":"Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer","volume":"17","author":"A","year":"2015","journal-title":"HPB (Oxford)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S471058","article-title":"Tumor markers in differential diagnosis of benign ovarian masses","volume":"16","author":"Li","year":"2024","journal-title":"IJWH"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188409","article-title":"Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter","volume":"1875","author":"Luo","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12204","article-title":"Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review","volume":"41","author":"Yang","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2023.24.12.4263","article-title":"D-dimer, fibrinogen and tumor marker levels in patients with benign and Malignant ovarian tumors","volume":"24","author":"Farzaneh","year":"2023","journal-title":"Asian Pac J Cancer Prev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00389-5","article-title":"Endometriosis is a chronic systemic disease: clinical challenges and novel innovations","volume":"397","author":"Taylor","year":"2021","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2013.255","article-title":"Endometriosis: pathogenesis and treatment","volume":"10","author":"Vercellini","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199581","article-title":"Systemic immune and tumor marker profiles in ovarian and deep infiltrating endometriosis: associations with disease severity and symptom burden","volume":"26","author":"Ram\u00edrez-Pavez","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/1.2.173","article-title":"CA125 and endometriosis","volume":"1","author":"Muyldermans","year":"1995","journal-title":"Hum Reprod Update"},{"key":"B13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/s0020-7292(99)00046-6","article-title":"Tumor markers in endometriosis","volume":"66","author":"Abr\u00e3o","year":"1999","journal-title":"Int J Gynaecol Obstet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1177\/0300060515583076","article-title":"Diagnostic value of serum CA125, CA19-9 and CA15-3 in endometriosis: A meta-analysis","volume":"43","author":"Shen","year":"2015","journal-title":"J Int Med Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/00001703-199112000-00019","article-title":"Endometriosis and associated pathology","volume":"3","author":"Stovall","year":"1991","journal-title":"Curr Opin Obstet Gynecol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26093979","article-title":"Endometriosis: challenges in clinical molecular diagnostics and treatment","volume":"26","author":"Rosendo-Chalma","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2009.01122.x","article-title":"Massive peritoneal fluid and markedly elevated serum CA125 and CA19-9 levels associated with an ovarian endometrioma","volume":"35","author":"Park","year":"2009","journal-title":"J Obstet Gynaecol Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/s0301-2115(02)00139-2","article-title":"Elevated serum CA125 and CA19-9 due to the spontaneous rupture of ovarian endometrioma","volume":"105","author":"Kurata","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.44256","article-title":"Bilateral endometriotic cystic ovaries and huge splenic epithelial cyst with elevated CA-125, CA19-9: A report of a rare case","volume":"15","author":"Abdulla","year":"2023","journal-title":"Cureus"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.29252\/ijrm.16.6.413","article-title":"Adnexal mass with extremely high levels of CA-125 and CA19-9 but normal Human Epididymis Protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA): Endometriosis or ovarian Malignancy? A case report","volume":"16","author":"Khodaverdi","year":"2018","journal-title":"Int J Reprod BioMed"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1046\/j.0004-8666.2003.00088.x","article-title":"Unusually elevated serum carbohydrate antigen 125 (CA125) and CA19-9 levels as a result of unruptured bilateral endometrioma","volume":"43","author":"Yilmazer","year":"2003","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/s0301-2115(98)00003-7","article-title":"Drastic elevation of serum CA125, CA72-4 and CA19-9 levels during menses in a patient with probable endometriosis","volume":"78","author":"Imai","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(91)90229-e","article-title":"Ovarian chocolate cyst with markedly elevated serum CA19-9 level: a case report","volume":"42","author":"Takemori","year":"1991","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.71503","article-title":"Clear cell carcinoma arising from adenomyotic cyst: A case report","volume":"16","author":"Morishita","year":"2024","journal-title":"Cureus"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1996.0233","article-title":"Rapid growth of an ovarian clear cell carcinoma expressing LH\/hCG receptor arising from endometriosis during early pregnancy","volume":"62","author":"Kobayashi","year":"1996","journal-title":"Gynecol Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-010-0052-y","article-title":"A case of diaphragmatic clear cell carcinoma in a patient with a medical history of ovarian endometriosis","volume":"15","author":"Fujiu","year":"2010","journal-title":"Int J Clin Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.88718","article-title":"The great mimicker: extragonadal endometriosis presenting as an appendiceal mass and acute appendicitis","volume":"17","author":"Ha","year":"2025","journal-title":"Cureus"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1846804\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:20:43Z","timestamp":1784607643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1846804\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":27,"alternative-id":["10.3389\/fonc.2026.1846804"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1846804","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"article-number":"1846804"}}